Insmed Inc
NASDAQ:INSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insmed Inc
NASDAQ:INSM
|
US |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
B
|
Bank of Nova Scotia
XMUN:BKN
|
CA |
|
S
|
SolGold PLC
XBER:S8F
|
AU |
|
M
|
Manhattan Associates Inc
SWB:MHT
|
US |
|
N
|
Natwest Group PLC
XHAM:RYS1
|
UK |
|
A
|
Alps Alpine Co Ltd
XMUN:ALE
|
JP |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
N
|
Neodecortech SpA
F:FM2
|
IT |
|
F
|
Fast Retailing Co Ltd
XBER:FR7
|
JP |
|
S
|
SolGold PLC
SWB:S8F
|
AU |
|
Indoco Remedies Ltd
BSE:532612
|
IN |
|
A
|
Alps Alpine Co Ltd
F:ALE
|
JP |
|
Taboola.com Ltd
F:1FY
|
US |
|
Stabilis Solutions Inc
NASDAQ:SLNG
|
US |
|
Isetan Mitsukoshi Holdings Ltd
F:4HP
|
JP |
|
Natwest Group PLC
F:RYSD
|
UK |
|
B
|
Blue Label Telecoms Ltd
XMUN:5TP
|
ZA |
|
Third Coast Bancshares Inc
NASDAQ:TCBX
|
US |
|
S
|
Sansiri PCL
SET:SIRI
|
TH |
|
T
|
Telstra Group Ltd
OTC:TLGPY
|
AU |
Bankruptcy Probability
Insmed Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Insmed Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Insmed Inc
NASDAQ:INSM
|
25B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Insmed Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Insmed Inc has total debt of 724.2m USD. This includes both short-term (0 USD) and long-term (724.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
